Navigate Titan Pharmaceuticals, Inc.
Home
About
Overview
Management Team
Board of Directors
Careers
News
Overview
Press Releases
Events
Presentations
In the News
Media Resources
Investors
Overview
News / Events
Company Information
SEC Filings
Corporate Governance
Contact
Search
All SEC Filings
Home
Investors
SEC Filings
All SEC Filings
Investors
Navigate Investors
Overview
News / Events
Company Information
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filter Filings:
View All
10-12G
10-12G/A
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB40
10QSB
15-12B
15-12G
25
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DEFN14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PREN14A
PRRN14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
10/24/24
8-K
Current report filing
2
08/21/24
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
4
08/19/24
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Related Documents
EX-2.1
EX-99.1
62
08/19/24
8-K
Current report filing
Related Documents
EX-2.1
EX-99.1
62
08/15/24
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-32.1
14
08/15/24
NT 10-Q
Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
2
05/15/24
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-32.1
14
04/26/24
RW
Registration Withdrawal Request
1
04/05/24
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
3
04/05/24
3
Initial statement of beneficial ownership of securities
1
<< Previous
1
2
3
4
5
6
7
8
9
10
...105
Next >>